BTK inhibitors and anti-CD20 monoclonal antibodies for treatment-naïve elderly patients with CLL

by Andrew Rogers, Jennifer A. Woyach
Published 2020-03-01

Incidence and survival of hematological cancers among adults ages ≥75 years

by Jessica L. Krok‐Schoen, James L. Fisher, Julie A. Stephens, Alice Mims, Sabarish Ayyappan, Jennifer A. Woyach, Ashley E. Rosko
Published 2018-07-01

Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL

by Timothy L. Chen, Bonnie Harrington, Jean Truxall, Ronni Wasmuth, Alexander Prouty, Shelby Sloan, Amy M. Lehman, Deepa Sampath, Eric Orlemans, Robert A. Baiocchi, Lapo Alinari, John C. Byrd, Jennifer A. Woyach, Erin Hertlein
Published 2021-02-01

Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry

by Wen-Hao Guo, Xiaoli Qi, Xin Yu, Yang Liu, Chan-I Chung, Fang Bai, Xingcheng Lin, Dong Lu, Lingfei Wang, Jianwei Chen, Lynn Hsiao Su, Krystle J. Nomie, Feng Li, Meng C. Wang, Xiaokun Shu, José N. Onuchic, Jennifer A. Woyach, Michael L. Wang, Jin Wang
Published 2020-08-01

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia

by Janek S. Walker, Zachary A. Hing, Bonnie Harrington, Jordan Baumhardt, Hatice Gulcin Ozer, Amy Lehman, Brian Giacopelli, Larry Beaver, Katie Williams, Jordan N. Skinner, Casey B. Cempre, Qingxiang Sun, Sharon Shacham, Benjamin R. Stromberg, Matthew K. Summers, Lynne V. Abruzzo, Laura Rassenti, Thomas J. Kipps, Sameer Parikh, Neil E. Kay, Kerry A. Rogers, Jennifer A. Woyach, Vincenzo Coppola, Yuh Min Chook, Christopher Oakes, John C. Byrd, Rosa Lapalombella
Published 2021-01-01